Honeywell Strengthens Digital Automation Capabilities in Life Sciences with Acquisition of Performix Inc.

0

– Performix Manufacturing Execution System Software to Strengthen and Expand Honeywell’s Solutions Portfolio for the Life Sciences Industry

– Software helps pharmaceutical and biotechnology customers optimize complex manufacturing processes

HOUSTON, September 27, 2021 / PRNewswire / – Honeywell (NASDAQ: HON) today announced the acquisition of privately-held Performix Inc., a provider of manufacturing execution system (MES) software for the pharmaceutical and biotechnology industries. The acquisition builds on Honeywell’s strategy to create the world’s leading integrated software platform for life science customers who strive for faster compliance, improved reliability and better production throughput at the highest quality levels.

Performix MES software will join Honeywell’s broad and growing portfolio of automation solutions for the life science industry, including the recently acquired Sparta Systems quality management software (QMS) and Honeywell’s Experion.® Process knowledge system. The combined offerings will meet the needs of life science customers throughout the lifecycle of their products, from the execution of automation projects to optimum production and sustainable quality.

“The Performix Manufacturing Execution System software allows us to extend our capabilities and further accelerate Honeywell’s connected life sciences vision of integrating data from multiple systems into a manufacturing ecosystem that guarantees quality, compliance and efficiency, ”said Ujjwal Kumar, president of Honeywell Process Solutions. “Honeywell can now offer customers a tailor-made solution designed for their specific industry that combines process automation, production management, quality management and data analysis in a single software suite.

The Performix MES platform offers a modular set of capabilities that address key components of the manufacturing process. The platform supports manufacturing of products through digital procedures and batch applications that include product recipe, workflow instructions, and lot numbers for traceability. The platform also provides compliance and auditability information while meeting business needs such as analysis, analysis and manufacturing intelligence.

“The addition of Performix’s state-of-the-art manufacturing execution system software to Honeywell’s already strong portfolio will strengthen Honeywell’s ability to provide critical solutions to pharmaceutical and biotech manufacturers as they digitally transform their operations. “Said Sham Afzalpurkar, President and CEO of Performix Inc.” As a combined business, Performix will benefit from Honeywell’s global reach and strong customer base. Together, we can accelerate product expansion to provide a global set of digital solutions that meet the growing complexity of today’s manufacturing.

Performix Inc. is headquartered in Houston, with additional offices in India. The company serves some of the world’s largest pharmaceutical and biotechnology companies. The Performix management team is expected to join Honeywell. Terms of the deal were not disclosed and there is no change in Honeywell’s financial outlook following the acquisition.

Honeywell (www.honeywell.com) is a Fortune 100 technology company that provides industry-specific solutions that include aerospace products and services; control technologies for buildings and industry; and performance materials globally. Our technologies are helping everything from airplanes, buildings, manufacturing plants, supply chains and workers become more connected to make our world smarter, safer and more sustainable. For more Honeywell news and information, please visit www.honeywell.com/newsroom.

This press release contains certain statements which may be considered “forward-looking statements” within the meaning of Section 21E of the Securities Exchange Act of 1934. All statements, other than statements of historical fact, which relate to business, events or developments that we or our management intends, expects, projects, believes or anticipates will occur or may occur in the future are forward-looking statements. These statements are based on certain assumptions and assessments made by our management in light of their experience and their perception of historical trends, current economic and industrial conditions, expected future developments and other factors they deem appropriate. The forward-looking statements included in this press release are also subject to a number of important risks and uncertainties, including, but not limited to, economic, competitive, government and technological factors affecting our operations, markets, products, services. and price. These forward-looking statements are not guarantees of future performance, and actual results, developments and business decisions may differ from those contemplated by such forward-looking statements. We identify the main risks and uncertainties that affect our performance in our Form 10-K and other documents filed with the Securities and Exchange Commission.

Cision

View original content: https://www.prnewswire.com/news-releases/honeywell-bolsters-digital-automation-capabilities-in-life-sciences-through-acquisition-of-performix-inc-301385943.html

SOURCE Honeywell


Source link

Leave A Reply

Your email address will not be published.